Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × naquotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 791 Carboplatin 685 Paclitaxel 641 Bevacizumab 636 pembrolizumab 604 Cisplatin 600 Gemcitabine 536 Docetaxel 501 Rituximab 487 Radiotherapy 482 Dexamethasone 434 Nivolumab 410 Doxorubicin 386 Capecitabine 340 Fluorouracil 339 Etoposide 313 Oxaliplatin 292 Pemetrexed 288 Cytarabine 287 Lenalidomide 285 Prednisone 285 Erlotinib Hydrochloride 275 fludarabine phosphate 274 Leucovorin 264 fludarabine 261 Trastuzumab 254 Bortezomib 249 Filgrastim 248 Vincristine 247 Cetuximab 234

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02588261 2024-12-10

SOLAR

Astellas Pharma Inc

Phase 3 Terminated

530 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡